Financial results - ANMED IMOB SRL

Financial Summary - Anmed Imob Srl
Unique identification code: 35211760
Registration number: J26/1114/2015
Nace: 4221
Sales - Ron
333.792
Net Profit - Ron
277.308
Employee
5
The most important financial indicators for the company Anmed Imob Srl - Unique Identification Number 35211760: sales in 2023 was 333.792 euro, registering a net profit of 277.308 euro and having an average number of 5 employees. Firma isi desfasoara activitatea in domeniul Lucrari de constructii a proiectelor utilitare pentru fluide having the NACE code 4221.
Sales - Ron100K3.3K14K315K379K225K7.1K334K2016201620172017201820182019201920202020202120212022202220232023

Sales, Profit, Employees, Debts, Capitals, Financial Results - Anmed Imob Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 99.760 3.284 13.968 315.047 379.367 225.226 7.097 333.792
Total Income - EUR - - 99.760 3.284 13.968 315.048 379.367 225.226 7.100 400.303
Total Expenses - EUR - - 9.110 6.194 4.852 201.262 158.529 115.853 40.414 118.992
Gross Profit/Loss - EUR - - 90.649 -2.910 9.116 113.786 220.839 109.374 -33.313 281.311
Net Profit/Loss - EUR - - 89.652 -2.943 8.976 110.636 216.352 107.121 -33.384 277.308
Employees - - 3 2 1 3 4 1 1 5
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate. In the last year of activity, the sales increased by 4,617.4%, from 7.097 euro in the year 2022, to 333.792 euro in 2023. The Net Profit increased by 277.308 euro, from 0 euro in 2022, to 277.308 in the last year.
Sales - Ron100K3.3K14K315K379K225K7.1K334K2016201620172017201820182019201920202020202120212022202220232023
Net Profit - Ron90K-2.9K9K111K216K107K-33K277K2016201620172017201820182019201920202020202120212022202220232023
Employees321341152016201620172017201820182019201920202020202120212022202220232023

Check the financial reports for the company - Anmed Imob Srl

Rating financiar

Financial Rating -
Anmed Imob Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Anmed Imob Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Anmed Imob Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Anmed Imob Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Anmed Imob Srl - CUI 35211760

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 0 0 0 38.210 46.604 35.025 73.520 17.514
Current Assets - - 89.696 86.695 90.780 261.369 431.356 142.507 33.727 389.765
Inventories - - 0 0 0 18.393 27 27 27 27
Receivables - - 89.514 82.088 80.948 109.525 428.579 81.402 33.237 33.976
Cash - - 182 4.606 9.832 133.450 2.749 61.078 463 355.763
Shareholders Funds - - 89.696 85.235 88.683 195.717 408.360 172.335 -30.207 247.087
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 0 1.459 2.097 103.861 69.600 5.197 137.455 160.192
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4221 - 4221"
CAEN Financial Year 4221
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 389.765 euro in 2023 which includes Inventories of 27 euro, Receivables of 33.976 euro and cash availability of 355.763 euro.
The company's Equity was valued at 247.087 euro, while total Liabilities amounted to 160.192 euro. Equity increased by 277.203 euro, from -30.207 euro in 2022, to 247.087 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Anmed Imob Srl

Review
0.00
(0 reviews)
5 stars
(0)
4 stars
(0)
3 stars
(0)
2 stars
(0)
1 star
(0)

Comments - Anmed Imob Srl

Similar services useful for checking companies and business development.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.